LifeSpan Signs Aventis as Subscriber to GPCR Database | GenomeWeb

NEW YORK, Oct. 9 – LifeSpan BioSciences of Seattle said Tuesday it had signed Aventis Pharma as its sixth subscriber to its G protein-coupled receptors database.

The database Lifespan will provide to Aventis of Strasbourg, France, includes information on non-olfactory GPCRs. The database, which is designed to help users to identify and prioritize potential drug targets, was designed to be used by Aventis’ branches in the US, Germany, and France.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic analysis of pollutant-tolerant fish, and more.

Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.

New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.

NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.